SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FAQ : ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth has delivered CAGR and average rolling returns as follows :

1 Year 3 Year 5 Year 9 Year
CAGR(%) 1.13 25.23 16.11 N/A
Average Rolling Returns(%) 27.49 23.31 24.43 N/A

The Current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is ₹38.68.

You should look for a fund with better more consistent performance track record. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth fund’s expense ratio is 1.87%

The process for redemption is

  • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
  • You will get information about the redemption and the NAV at which redeemed.
  • The amount will be deposited in the designated bank account.

The AUM of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is currently ₹6,293 Crores.

The Top three stocks are Sun Pharma Inds., Cipla and Mankind Pharma and account for 28% of its portfolio. Top 5 and 10 stocks of fund account for 40% and 61% of fund’s portfolio respectively.

Top three sectors of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth fund are Healthcare, Miscellaneous and Retail accounting for 99% of the total portfolio.

Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth Fund is Equity - Sectoral Fund - Pharma & Health Care.

Dharmesh Kakkad manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth Fund.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth current PE ratio is 39.67 and PB ratio is 4.72

The asset allocation of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is Stocks : 97.62%, Debt : 2.39% and Gold : 0%

The minimum SIP amount for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is ₹100.00 and minimum lumpsum is ₹5000.00

The exit load for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth is 1% on or before 15 days, Nil after 15 days

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×